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Left ventricuiar thrombi with mobile or protruding segments 
seen by echocardiography ave been demonstrated to associ- 
ate with a high risk of arterial embolization (l), with reported 
incideaces ranging from 22% to 100% (2,3). Controversy exists 
about the best treatment for this condition (4-20). Initiai 
results with urokinase were promising (4), but serious compli- 
cations during thrombolysis, such as systemic embolization and 
cerebral breeding, have beer> reported more recently (5). 
Complete resolution of left ventricular thrombi with warfarin 
over a prolonged period has been reported previously 
(3,5,7,21). In a retrospective assessment (7), only 2 of 15 
thrombi disappeared uring 4 months of oral anticoagulant 
therapy, and other nonrandomized studies showed 50% to 
59% complete r solution of left ventricular thrombus with the 
use of warfarin or low dose heparin for 15 days (21) to 6 to 9 
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months (3). However, there has been no systematic trial of 
anticoagulation with the use of a full loading dose of heparia 
for this condition; therefore, its value remains controversial 
(3,8,13,14,17,lS,20). 
in paticntb with this type ofthrombus who were not suitable 
candidates for thrombolytic therapy or surgical intervention, 
we have used high-dose heparin empirically with promising 
results. The present study was therefore undertaken i a series 
of consecutive patients to evaluate prospectively the efficacy of 
high dose intravenous heparin for treating mobile or protrud- 
ing left ventricular thrombi, as assessed by clinical outcome 
and serial echocardiography. 
Mle&IRW.Is 
patients. Between January 1990 and July 1993,23 patients 
admitted to the University Hospital in Hamburg and Herz- 
Kreislauf-KJinik in Bevensen had 25 echocardiographically 
documented left ventricular thrombi that were mobile or 
protruded into the left ventricular cavity (Table 1). hll patients 
were suitable candidates for anticoagulation (11 women, 12 
men; mean [“_SD] age 61 ?I 12 years, range 36 to 83). TWO 
patients were referred for evaluation of the cardiac source of 
the embolism, and the remaining patients were referred pri- 
marily for evaluation f left ventricular function. The etiologies 
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Table 1. Patient Characteristics 
Pt No.1 
Age (~0 
Time After Thrombus 
l/56 CUD 
2/6S DCM 
3136 DA (mycxarditis) 
4168 CHD 
St70 CHD 
6167 CHD 
7183 CHD 
859 CHD 
9153 CHD 
IOn1 DCM 
II/f,3 CHD 
121flY CWD 
13170 CHD 
14/40 11111) 
15149 CUD 
16&I CHD 
17174 CHD 
I#/42 Postmyxomoctomy 
19146 CHD 
20/7H CHD 
21147 CtlD 
??I54 CHD 
5Yr 
6yr 
Unknown 
I mo 
2mo 
30 days 
3Yr 
IO duys 
2 days 
2yr 
3yr 
Unknown 
UilkflOWl~ 
t Yr 
~nktlo~ 
2Yr 
7Yr 
Ilnf, AN 
Global 
Global 
Ant, Sept 
Inf. Ant 
Ant 
Ant, sept 
Ant, §ept 
Ant. Scpt 
Global 
GlObi 
Post&It, AN 
Ant. Ljrt 
Ant, kpt 
Ant. AN 
Ant, Sept 
Ant, Sept 
Apicul 
Ant, Aid 
Ant, Lat. Inf 
Ant, Lat, Inf 
Ant, Lot 
Basal Inf 
Apical 
Apical 
Apical 
Apical 
Apical 
Apical 
Apical 
Apical 
Apical 
Apical 
Basal Post 
Apical 
Apical 
Apic;ll 
FipiCiil 
Apical 
Apicid 
Apical 
Apical 
Apica 
Ant 
AN = aneurysm; Ant = anterior wa 
cr-rdiomyopathy: Inf = inferior wall; Lat = loteral wall; LVEF = left ventricular ejection fraction; MI = rnyoc~~r~~~~~ 
infarction; Post = posterior; Pt = patient; Sept = septul wall; WMA = regional wull motion abnormality. 
are presented in Table 1. Two patients with coronary disease 
were taking warfarin >1 year and had prothr~mbin times 
between 1.5 and 1.8 times the normal control value at the 
time of admission; 16 were taking aspirin; and 5 were not 
receiving anticoagulana or antiplatelet drugs. Two patients with 
recent myocardial infarction (~8 days) had received thrombo- 
@tie therapy and were receiving low dose subcutaneous hepa- 
Per day). Global bfi ventricular ejection 
onal wall motion abnormalities are presented 
in Table 1. 
E~h~~~i~~p~. A commercially available Hewlett- 
Packard Sonos 1OUO and an Acuson 128 XP/lO were used. 
Transthoracic echocardiography was performed with a 2.5-lklH2 
tramxker and recorded on 25.in. videotape. Follow-up studies 
were performed very 2 to 7 days, depending on the clinical 
course. Mobile or prottudmg left ventricular th ombus was diag- 
nosed with transthoracic echocardiogmphy in 21of the patients 
and with tramesophageal echocardiography in the other 3, in 
whom there was difkulty characterizing the thrombus by trans- 
thoraek ec aphy because of inadequate image quality. 
Two observers evaluated the echocardiographic recordings 
independently foroverall left ventricular function, regional 
wall motion abnormalities and the presence or absence of 
intracavitary thrombus and its morphologic features (size, 
mobility, protrusion and homogeneity). Forthe diagnosis of
left ventricular thrombus, an echogenic mass had to be seen in 
at least wo orthogonal views, and both had to be distinguish- 
and associated with a regional 
wall or global ~y~~iues~a. 
in this tudy the thrombus had to be ~rot~~dillg or mobile in 
multiple views, defined by one of the following criteria: 1) a 
broad-based protuberant thrombus without amobile compo- 
nent in 10 patients; 2)a mobile intracavitary thrombus with a 
narrow stalk in 1 patient; 3) a broad-based 
with a protruding part and one or more mobile parts in 12 
patients. There was a 100% concordance of assessment of 
echocardiographic rotrusion or mobility of the thrombus by 
two experienced observers (C.C. and S.C.W.H.). Thrombus 
size was measured from the echocardiographic lane, usually 
from the apical long-axis or four-chamber view, showing the 
largest area of thrombus. Follow-up measurements were per- 
formed in the same echocardiographic plane as during the 
baseline r cording, asdepicted in Figure 1. The mean interob- 
server variability of the measurement of thrombus size was 0.85 
and intraobsenrer variability was 0.45 cm2. 
eparin therapy. As soon as a protuberant or mobile 
thrombus was diagnosed, heparin was begun intravenously at a
dose of 400 lW/kg per day, adjusted to maintain the partial 
thromboplastin time at 2.0 to 2.5 times the normal control 
value (partial thromboplastin time normal range 34 to 58 s). 
Heparin was stopped when serial ~~bocardiogra~~y showed 
that the thrombus had disappeared chocardiographically or 
that only a small, flat residual mural thrombus without a 
mobile or protruding segment was present. 
JACC Vol. 24. No. 5 
November 1. 1994: 130.5-9 HE9K ET Al_. HEPARIN THERAPY FOR LEFT VENTRKULAR THROMBUS 1307 
Plgure 1. A. Apical long-axis view echocardiogram showing three 
protruding and mobile thrombi n a drug addict with mild global 
hypokinesia of a mildly dilated left ventricle. e Two weeks after high 
dose intravenous heparin administration, all left ventricular thrombi 
disappeared, both in the same imaging plane and in all other views (not 
shown). 
S~~~~~tic~~ analysis. Data are presented as the mean value 
21s rombus ize before and after be 
compared by the Wilcoxon signed-rank test. 
During high dose heparin therapy, the size of the left 
ventricular thrombi decreased from 3.9 i: 2.6 cm’ (mean + 
SD) (range 0.55 to 11.3) to 0.16 4 0.38 cm’ (range 0 to 1.5, p < 
0.0001). Twenty-one f the 25 thrombi in 19 of the 23 patients 
completely disappeared. The other four thrombi were cignifi- 
cantly smaller: Their sizes after heparin therapy were 1.0, I,5, 
0.35 and 0.32 cm” (mean 0.8 t 0.5 cm’) (Fig. 2). All of the 25 
thrombi mproved with respect o size or high risk features 
during high dose heparin therapy. All had lost their mobile 
component, and only one of them still protruded in one 
patient. This patient died of abrupt coronary bypass graft 
occlusion, and an autopsy revealed a small residual left ven- 
tricular thrombus consistent with the echocardiographic find- 
ings. 
~~~~e 2. ~~~~vi~~al thrombus size assessed by serial two-dimensional 
ecll(~cardio~ral~l~y in a!! paiicnts before and after high dose intrave- 
nous hepariil a~~~j~l~strati[)l~. 
patients experienced e9nbolic ev 
therapy. No emboli were detect 
ose heparin therapy. The mean 
f 7,981 ID/day (range 16,000 
rtial tbromboplasti~, time was 107 t- 
The only serious hemorrhagic episod 
gastrointestinal hemorrhage that was s 
ically without he need for blood tra~sfusiou. 
co1 cations, such assmall hemato 
tients. The mean duration of heparin 
(range 7 to 22), de~endiu~ onwhen 
the thrombus disappeared echocardiographically or lost its 
ft ventricular dilaiion, reduced left ventric- 
ular ejection fraction (<50%) or regional wall motion abnor- 
malities were treated with warfarin after hos arge. 
One ~atiellt who was transferred to another ho only 
4 days of high dose heparin treatment was excluded from the 
study, He had esophageal carcinoma nd a large mobile apical 
thrombus. The thrombus remained mobile, but its size de- 
creased after 4 days of high dose heparin. The patient was 
transferred to another hospital, and his heparin regimen was 
changed to low dose subcutaneous heparin (5,000 IU twice a 
day). He subsequently had an embolic stro 
termination of intravenous high dose heparin. 
phy revealed a further decrease in thrombus size after this 
event. 
This study demonstrates that high dose intravenous heparin 
is highly effective in completely resolving high risk left ventric- 
ular thrombi. The risk of hemorrhagic complications i  low in 
a hospital setting with rigorous control of bleeding variables. 
Further studies are quired to address whether the reduction 
in embolic risk by rapid resohttion of left ventricular thrombus 
with high dose heparin would be maintained long term by 
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administration of an oral platelet inhibitor or oral anticoagu- 
lant. 
Me!c sm of action. The mechanism by which eparin 
an resolve a thrombus i speculative. We hypothesize that 
high dose intravenous heparin will prevent further deposition 
of thrombo:ic material onto the surface of the existing throm- 
bus and that the ndogenous thrombolytic system Will act on 
the surface of the thrombus, resulting inendogenous throm- 
bolysis. If endogenous thrombolysis occurs equentially, re- 
versing the incremental pattern of thrombus formation, new
layers of thrombus will be removed first, and older layers will
resolve later, preventing dislodgment and embolization. This 
tion may account for the absence of embolic events 
sustained period of endogenous thr~mbolysis. 
rate of embolic events has also been reported with 
oral anticoagulant therapy. However, the rate of swc&td 
re,solution f thrombus is relatively low and varies widely, from 
13% to 59% (6,7,11,13,21-23). Why high dose heparin appears 
to be more ffective in resolving left venlricular thrombus than 
oral anticonguiant is unclear. Rigorous mohitoring ofantico- 
agulation i -hospital, with avoidance of subtherapeutic levels, 
may have contributed to the higher efficacy of high dose 
heparir: compared with oral anticoagulation in an ambulatory 
setting, Close monitoring over a relatively short period in this 
study may also have reduced the likelihood of excessive 
anticoagulation, leading to bleeding complications. There rtas 
no embolic event during high dose heparin infusion and 
resolution ofthe thrombus in this study. owever, there have 
been xcasional reports (4,24,25) of embolic events during 
regular or low dose heparin therapy after acute myocardiai 
infarction. Larger studies will be necessary to determine 
whether there is a difference in embolic rate between high and 
low dose hcparin i  the treatment of left veatricular thrombus. 
Other therapeutic sptions. For a broad-based l ft ventric- 
ular thrombus without a mobile or protruding component, 
conservative th rapy with oral anti~oa~ul~t~on is usrtally con- 
sidered adequate because of the low risk of arterial emboiic 
events (12). Several studies (l-3) have demonstrated that 
mobile or protruding left ventricular thrombi carry a high 
embolic risk, reported to range from 22% to 100%. Therefore, 
a highly mobile thrombus with a prominent protruding seg- 
ment has been cvJnsidered to need more intensive medical or 
SU I therapy, particularly if the thrombus i located on a 
regisn of asynergy with a hyperkinetic adjacent wall (3). 
However, the optir?al therapy iscontroversial, because neither 
surgica1 removal nor thrombolytic agents are without major 
complications or subsequent u favorable events (8-l&23). 
A small proportion ofleft ventricular thrombi, <20%, have 
been reported (11,211 toresolve spontaneously after myo-car- 
dial infarction with or without oral anticoagulant therapy, A 
systematic prospective investigation f the efficacy of antico- 
agulation with high dose heparin for resolving left ventricular 
thrombus has not been reported. Thrombus resolution with 
oral anticoagulation over several months in small numbers of
Patients has been described (3,6,7,13,21); however, esults 
were inconsistent. Asinger et al. (1%) have Teported re;Jlution 
of six of seven thrombi after oral anticoagulant therapy for 9 t 
5 months. Incontrast, Visser et al. (7) have observed that Deft 
ventricular thrombus resolved in only 2 of 15 patients over a 
4-month period of oral a~licoa~~~atioo. 
anticoagulant therapy has been consistently 
reduce mbolic events in patients with left ve 
although the incidence of bleeding complications may be as 
high as 20% on long-term high dose oral anticoa 
For a left ventricular tb ~~~us with a ~~~j~e 0 
segment, and thus a high risk for ernb~~iza~i~~~ a ~leatme~t 
that would resolve the thrombus, orat least its risky compo- 
nents, without embolic or hemorrhagic ~~~rnpl~~~l~i~?~s would be 
ideal, This initial resolution of the thrombus could ahen be 
treatment with a low dose a~t~c~~u~~~~ or a 
bifor, such as aspirin. with a low i~~id~~~~e of 
bleeding complications. 
A previous tudy (4j from our hospital demonstrated 
successful resolution of IQ of 16 thmmbi with urokinase. Karen 
et al. (5) later reported two embolic events in four patients 
treated with stre~toki~ase or inase, with a tr~~~si~~~~ neu- 
rologic deficit in one patient a stroke followed by deilth in 
another. The risks of thrombolytic herapy, hemorrhagic com- 
d embolic events eem higher than i itially as- 
rthermore. throm~o~ytic therapy must be closely 
monitored inan intetlsive 
can be initiated on a reg 
thrombus resolution with hig 
least as good as the result of thrombolytic her 
Kremer et al. (4). However, comparisons be
hUardous because the age of the fhrombus an 
heart disease may be d 
previous study (cl), successful resolution was dependent on the 
age of the thrombus: Eight of nine fresh t rombi, which had 
developed within 4 weeks, were successfully lysed, compared 
with only two of seven older thrombi. The success rate of 
thrombolysis appears to depend on the morphology of the 
thrombi or the underlying heart disease, orboth: In the study 
of Kremer et al. (4), only large thrombi were included, and 
thrombi located in aneurysms or associated with severe left 
ventricular dysfunction did not respond well to urokinase. In
the present study, we included all mobile or protruding 
thrombi regardless of size; however, the ages of the thrombi 
were not known. The proportion of thrombi in aneurysms is 
lower, only 4 of 23, compared with the study by Kremer et al. 
(4). 
Surgical removal of large, mobile left ventricular thrombi 
has been performed toreduce the risk of recurrent emboliza- 
tion (9,lQ). The indications for thrombectomy have differed 
from one institution to another and remain controversial. If 
the abnormal myocardial region remains, it may still predis- 
pose to new thrombus formation (14). Furthermore, it can be 
di&ult to surgically remove all thrombotic debris, and incom- 
plete removal of thrombotic material may result in emboliza- 
tion at operation. This approach may be indicated ina patient 
with a large mobile thrombus attached tothe wall by a thin 
stalk. This type of thrombus was een in only one patient in this 
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